Synthesis and biological evaluation of andrographolide derivatives as potent anti-HIV agents. 2012

Chunlei Tang, and Yajuan Liu, and Bin Wang, and Guolong Gu, and Liumeng Yang, and Yongtang Zheng, and Hai Qian, and Wenlong Huang
Center of Drug Discovery, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, P. R. China.

In an attempt to develop potent anti-HIV drugs, 20 andrographolide derivatives were designed, synthesized, and evaluated for their in vitro anti-HIV activity. The screening results revealed that five compounds showed potent anti-HIV activities with therapeutic indices (TI) above 10. The most promising compound 6f shows a significant TI close to 34.07, with the potency to be a new lead.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004224 Diterpenes Twenty-carbon compounds derived from MEVALONIC ACID or deoxyxylulose phosphate. Diterpene,Diterpenes, Cembrane,Diterpenes, Labdane,Diterpenoid,Labdane Diterpene,Norditerpene,Norditerpenes,Norditerpenoid,Cembranes,Diterpenoids,Labdanes,Norditerpenoids,Cembrane Diterpenes,Diterpene, Labdane,Labdane Diterpenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

Chunlei Tang, and Yajuan Liu, and Bin Wang, and Guolong Gu, and Liumeng Yang, and Yongtang Zheng, and Hai Qian, and Wenlong Huang
March 2014, Chemical biology & drug design,
Chunlei Tang, and Yajuan Liu, and Bin Wang, and Guolong Gu, and Liumeng Yang, and Yongtang Zheng, and Hai Qian, and Wenlong Huang
December 2014, Bioorganic & medicinal chemistry letters,
Chunlei Tang, and Yajuan Liu, and Bin Wang, and Guolong Gu, and Liumeng Yang, and Yongtang Zheng, and Hai Qian, and Wenlong Huang
March 2021, European journal of medicinal chemistry,
Chunlei Tang, and Yajuan Liu, and Bin Wang, and Guolong Gu, and Liumeng Yang, and Yongtang Zheng, and Hai Qian, and Wenlong Huang
January 2018, Current pharmaceutical design,
Chunlei Tang, and Yajuan Liu, and Bin Wang, and Guolong Gu, and Liumeng Yang, and Yongtang Zheng, and Hai Qian, and Wenlong Huang
October 2014, European journal of medicinal chemistry,
Chunlei Tang, and Yajuan Liu, and Bin Wang, and Guolong Gu, and Liumeng Yang, and Yongtang Zheng, and Hai Qian, and Wenlong Huang
September 2011, Bioorganic & medicinal chemistry,
Chunlei Tang, and Yajuan Liu, and Bin Wang, and Guolong Gu, and Liumeng Yang, and Yongtang Zheng, and Hai Qian, and Wenlong Huang
June 2015, Bioorganic & medicinal chemistry letters,
Chunlei Tang, and Yajuan Liu, and Bin Wang, and Guolong Gu, and Liumeng Yang, and Yongtang Zheng, and Hai Qian, and Wenlong Huang
July 2017, Bioorganic & medicinal chemistry letters,
Chunlei Tang, and Yajuan Liu, and Bin Wang, and Guolong Gu, and Liumeng Yang, and Yongtang Zheng, and Hai Qian, and Wenlong Huang
March 2014, Bioorganic & medicinal chemistry letters,
Chunlei Tang, and Yajuan Liu, and Bin Wang, and Guolong Gu, and Liumeng Yang, and Yongtang Zheng, and Hai Qian, and Wenlong Huang
July 2005, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!